Logo image of ZK

ZEEKR INTELLIGENT TECHNO-ADR (ZK) Stock Fundamental Analysis

USA - NYSE:ZK - US98923K1034 - ADR

29.94 USD
+0.51 (+1.73%)
Last: 9/19/2025, 8:04:00 PM
29.5 USD
-0.44 (-1.47%)
After Hours: 9/19/2025, 8:04:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ZK. ZK was compared to 37 industry peers in the Automobiles industry. Both the profitability and financial health of ZK have multiple concerns. ZK is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ZK has reported negative net income.
ZK Yearly Net Income VS EBIT VS OCF VS FCFZK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2B -2B -4B -6B -8B

1.2 Ratios

ZK has a better Return On Assets (-5.39%) than 62.16% of its industry peers.
Industry RankSector Rank
ROA -5.39%
ROE N/A
ROIC N/A
ROA(3y)-30.39%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZK Yearly ROA, ROE, ROICZK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

Looking at the Gross Margin, with a value of 18.91%, ZK is in the better half of the industry, outperforming 75.68% of the companies in the same industry.
In the last couple of years the Gross Margin of ZK has remained more or less at the same level.
ZK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5YN/A
ZK Yearly Profit, Operating, Gross MarginsZK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -20 -40 -60

More info and screens

0

2. Health

2.1 Basic Checks

ZK does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZK has more shares outstanding than it did 1 year ago.
ZK has a worse debt/assets ratio than last year.
ZK Yearly Shares OutstandingZK Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 50M 100M 150M 200M 250M
ZK Yearly Total Debt VS Total AssetsZK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 0.28, we must say that ZK is in the distress zone and has some risk of bankruptcy.
ZK's Altman-Z score of 0.28 is in line compared to the rest of the industry. ZK outperforms 51.35% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.28
ROIC/WACCN/A
WACC6.32%
ZK Yearly LT Debt VS Equity VS FCFZK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5B -5B -10B

2.3 Liquidity

A Current Ratio of 0.59 indicates that ZK may have some problems paying its short term obligations.
ZK's Current ratio of 0.59 is on the low side compared to the rest of the industry. ZK is outperformed by 72.97% of its industry peers.
A Quick Ratio of 0.49 indicates that ZK may have some problems paying its short term obligations.
ZK's Quick ratio of 0.49 is on the low side compared to the rest of the industry. ZK is outperformed by 67.57% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.49
ZK Yearly Current Assets VS Current LiabilitesZK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10B 20B 30B 40B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 60.83% over the past year.
ZK shows a strong growth in Revenue. In the last year, the Revenue has grown by 38.98%.
ZK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 126.56% yearly.
EPS 1Y (TTM)60.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.33%
Revenue 1Y (TTM)38.98%
Revenue growth 3Y126.56%
Revenue growth 5YN/A
Sales Q2Q%37.55%

3.2 Future

Based on estimates for the next years, ZK will show a very strong growth in Earnings Per Share. The EPS will grow by 40.84% on average per year.
Based on estimates for the next years, ZK will show a very strong growth in Revenue. The Revenue will grow by 38.00% on average per year.
EPS Next Y50.48%
EPS Next 2Y46.33%
EPS Next 3Y40.84%
EPS Next 5YN/A
Revenue Next Year52.57%
Revenue Next 2Y40.57%
Revenue Next 3Y38%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ZK Yearly Revenue VS EstimatesZK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
ZK Yearly EPS VS EstimatesZK Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 1 -1 2 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ZK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 456.67 indicates a quite expensive valuation of ZK.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ZK is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, ZK is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 456.67
ZK Price Earnings VS Forward Price EarningsZK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 200 300 400

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZK Per share dataZK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZK does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as ZK's earnings are expected to grow with 40.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.33%
EPS Next 3Y40.84%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZEEKR INTELLIGENT TECHNO-ADR

NYSE:ZK (9/19/2025, 8:04:00 PM)

After market: 29.5 -0.44 (-1.47%)

29.94

+0.51 (+1.73%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-14 2025-11-14
Inst Owners3.4%
Inst Owner Change8.38%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.67B
Analysts85
Price Target36.76 (22.78%)
Short Float %0.25%
Short Ratio1.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-52.16%
Min EPS beat(2)-161.65%
Max EPS beat(2)57.34%
EPS beat(4)2
Avg EPS beat(4)-311.1%
Min EPS beat(4)-1188.89%
Max EPS beat(4)57.34%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.63%
Min Revenue beat(2)-3.75%
Max Revenue beat(2)15.01%
Revenue beat(4)2
Avg Revenue beat(4)3.68%
Min Revenue beat(4)-4.51%
Max Revenue beat(4)15.01%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.45%
PT rev (3m)0.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)65.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 456.67
P/S 0.6
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)0.07
Fwd EY0.22%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS49.69
BVpS-13.2
TBVpS-14.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.39%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.91%
FCFM N/A
ROA(3y)-30.39%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.49
Altman-Z 0.28
F-ScoreN/A
WACC6.32%
ROIC/WACCN/A
Cap/Depr(3y)291.47%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.94%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.33%
EPS Next Y50.48%
EPS Next 2Y46.33%
EPS Next 3Y40.84%
EPS Next 5YN/A
Revenue 1Y (TTM)38.98%
Revenue growth 3Y126.56%
Revenue growth 5YN/A
Sales Q2Q%37.55%
Revenue Next Year52.57%
Revenue Next 2Y40.57%
Revenue Next 3Y38%
Revenue Next 5YN/A
EBIT growth 1Y53.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.21%
EBIT Next 3Y59.62%
EBIT Next 5YN/A
FCF growth 1Y312.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.62%
OCF growth 3Y71.86%
OCF growth 5YN/A